Table 6.
Variable | Readmissions Secondary to PLA or Treatment (n = 33) | Unrelated or No Readmissions (n = 87) |
P Values |
---|---|---|---|
Age, mean (range) | 62 (15–89) | 62 (13–92) | |
Comorbidities, no. (%) | |||
Malignancy | 13 (39) | 46 (53) | .187 |
Biliary disease | 10 (30) | 25 (29) | .866 |
Abscess size >5 (cm), mean (%)* | 15 (45) | 38 (44) | .911 |
Microbiology unknown, no. (%) | 6 (18) | 17 (20) | .979 |
Inpatient intervention, no. (%) | |||
Surgery | 4 (12) | 6 (7) | .355 |
Percutaneous aspiration | 6 (18) | 17 (20) | .866 |
Percutaneous drainage | 21 (64) | 55 (63) | .966 |
Antibiotics alone | 2 (6) | 9 (10) | .468 |
ID consult, no. (%) | 21 (64) | 57 (66) | .847 |
Discharge with IV antibiotics, no. (%) | 10 (30) | 21 (24) | .491 |
Discharge with drain, no. (%) | 23 (70) | 47 (54) | .120 |
Length of stay <5 days | 12 (36) | 29 (33) | .755 |
Length of antibiotic course <30 days | 13 (39) | 34 (39) | .975 |
Follow-up appointments <3 within 90 days, no. (%) | 16 (48) | 45 (52) | .894 |
Abbreviations: ID, infectious diseases; IV, intraveneous; PLA, pyogenic liver abscesses.
*Of 88 patients in which the abscess size was documented.